SEC Form 3 · accession 0001179110-18-000841
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Co /de Medicines
10% Owner
Period of report
Jan 5, 2018
Accepted (ET)
Jan 11, 2018 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | holding | — | — | — | 3,313,702 | D |
Table II — derivative securities
No Table II lines on this filing.